Trial Profile
The effect of Orexin receptor antagonist Suvorexant on REM sleep behavior disorder using Escitalopram(2)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2018
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary) ; Antidepressants; Clonazepam; Escitalopram
- Indications REM-sleep-behavior-disorder
- Focus Therapeutic Use
- 23 Oct 2018 New trial record